Lack of association between the -2518G/A polymorphism of the MCP-1 gene and ischaemic heart disease: a family-based investigation

Tissue Antigens. 2004 Aug;64(2):199-203. doi: 10.1111/j.0001-2815.2004.00281.x.

Abstract

Using two recently described family-based tests of association, the possible role of the functional -2518G/A polymorphism in the promoter region of the monocyte chemoattractant protein-1 (MCP-1) gene in the susceptibility to ischaemic heart disease (IHD) was investigated in a well-defined Irish population. One thousand and twelve individuals from 386 families with at least one member prematurely affected with IHD were genotyped for the MCP-1 -2518G/A polymorphism. Using the combined transmission disequilibrium test and the pedigree disequilibrium test, no association between the MCP-1 -2518G/A polymorphism and IHD was found. Our data demonstrate that, in an Irish population, the MCP-1 -2518G/A polymorphism is not strongly associated with IHD.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Chemokine CCL2 / genetics*
  • Female
  • Genetic Predisposition to Disease
  • Humans
  • Ireland
  • Male
  • Middle Aged
  • Myocardial Ischemia / genetics*
  • Polymorphism, Genetic*
  • Promoter Regions, Genetic / genetics
  • Promoter Regions, Genetic / physiology

Substances

  • CCL2 protein, human
  • Chemokine CCL2